ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
ALTE03N1: Key Adverse Events After Childhood Cancer
Protocol ID
ALTE03N1
Condition/s
Childhood Malignant Neoplasm
Diagnosis Stage
Previously treated
Location
QLD, WA, SA
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Trial Status
Open
Sites
Women's & Children's Hospital
Queensland Children's Hospital
Perth Children's Hospital
Study Type
Observational
Phase
Not applicable
Age Eligibility
up to 21 Years
International registry ID's
NCT00082745
Back to Registry
Study Title ALTE03N1: Key Adverse Events After Childhood Cancer
Protocol ID ALTE03N1
Disease (Sub Disease) Childhood Malignant Neoplasm
Diagnosis Stage Previously treated
Location QLD / WA / SA
Sponsor Children's Oncology Group
Collaborators National Cancer Institute (NCI)
Links https://clinicaltrials.gov/ct2/show/NCT00082745
Trial Status Open
Trial Open Date 24/03/2004
Sites Women's & Children's Hospital / Queensland Children's Hospital/ Perth Children's Hospital
Study Type Observational
Phase Not applicable
Age Eligibility up to 21 Years
International registry ID's NCT00082745

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168